MedTrace Logo

Effects of Hip Strength Training and Neuromuscular Electrical Stimulation on Functional Ankle Instability

NCT06125158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-04-10

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of two methods of elevating hip muscle strength on functional ankle instability(FAI). . The main question\[s\] it aims to answer are:

* Whether hip strength training and neuromuscular electrical stimulation of the gluteal muscles, respectively, based on conventional ankle training improves dysfunction in patients with FAI?
* Is there a difference in the efficacy of the above two interventions for FAI?

Conditions

  • Ankle Injuries and Disorders

Interventions

PROCEDURE

Conventional ankle training

The program included ankle elastic band resistance training and balance training, in which the elastic band resistance training required subjects to complete resistance training in ankle plantarflexion, dorsiflexion, inversion and eversion directions with the help of elastic bands; and the balance training required subjects to complete the movements of standing with eyes open, standing with eyes closed, and throwing and catching the ball on flat ground and BOSU ball.

PROCEDURE

Hip strength training

Hip strength training required subjects to complete resistance training in hip abduction and posterior extension, anterior step-up and lateral step-up exercises with the help of elastic bands.

PROCEDURE

Neuromuscular electrical stimulation

Neuromuscular electrical stimulation of the gluteus mediums and gluteus maximus muscles of the affected side was carried out using the TB6807 low-frequency therapeutic instrument (with prescription for neuromuscular electrical stimulation) manufactured by China Tangbang Science and Technology Company.

Sponsors & Collaborators

  • Tianjin University of Sport

    lead OTHER

Principal Investigators

  • Wei Zheng, PhD · Tianjin University of Sport

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-18
Primary Completion
2023-12-02
Completion
2023-12-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06125158 on ClinicalTrials.gov